Similar Jobs
See allAssociate Director, Drug Product
Pulmovant
US
CDMO Management
Quality By Design
Regulatory Affairs
Associate Director, Drug Substance (Process Chemistry)
Pulmovant
US
CMC
CDMO Management
Quality By Design
Vice President, CMC Development and Drug Delivery Innovation
Kailera Therapeutics
US
CMC
Drug Development
Regulatory Affairs
Role Impact:
- Drive development of an innovative inhaled dry powder portfolio through registration and commercialization.
- Provide technical leadership across CMC, manufacturing, and regulatory strategy.
Key Accountabilities:
- Lead formulation, scale-up, technology transfer, and validation with external CDMOs.
- Apply Quality by Design to establish control strategies and ensure product quality.
- Analyze performance and stability data to drive process improvements.
Candidate Profile:
- At least 10 years of drug product development, including late-stage inhalation products.
- Strong CDMO management, cGMP, and CMC submission experience.
- Independent, data-driven leader comfortable in a lean biotech environment.
Why This Role:
- Contribute to innovative therapies for serious pulmonary diseases.
- Own complex technical decisions and regulatory milestones.
Pulmovant
Pulmovant is a biotechnology company developing inhaled dry powder therapies for serious pulmonary diseases. It is a lean, collaborative organization focused on bringing innovative treatments to patients with significant unmet medical needs.